This Viewpoint discusses the I-SPY breast cancer trials as a model for the development of therapies for Alzheimer disease.
This Viewpoint discusses how arts-based medical therapies can improve patient quality of life and health care outcomes.
This Viewpoint discusses Nevada’s revisions to its Uniform Determination of Death Act and the rationales behind them.
This crossover cohort, case-control study uses medical records from the Research Patient Data Repository to determine the features, triggers, and risk factors of poststroke recrudescence among patients with a previous stroke.
This cohort study examines the risk of dementia in individuals who are born in the Stroke Belt but later reside in California.
This cohort study evaluates the use of phospho-tau levels, total-tau levels, and the phospho tau–total tau ratio as diagnostic and prognostic biomarkers in patients with traumatic brain injury.
This cohort study evaluates the association between plasma total tau level and cognitive decline as well as dementia in cognitively normal individuals.
This study examines the prevalence of intracranial aneurysm in women diagnosed with fibromuscular dysplasia.
This cross-sectional study investigates the association between brain metabolism and motor scores of patients with early Huntington disease.
This epidemiologic register-based study examines the 20-year epidemiologic trends of amyotrophic lateral sclerosis in the Piemonte and Valle d’Aosta regions of Italy.
This study examines whether large perivascular spaces visible on magnetic resonance imaging are associated with progression of the established magnetic resonance imaging markers of small vessel disease, cognitive decline, and increased risk of dementia.
This case-control study conducts whole-exome sequencing to evaluate endolysosomal-related variants and genes in early-onset Alzheimer disease.
This cohort study uses the database of the Manchester Centre for Genomic Medicine to analyze lymphocyte DNA of young patients who presented with meningioma or schwannoma before age 25 years.
This systematic review synthesizes studies that used zolpidem to treat neurologic disorders.
This cohort study assesses the role of the central nervous system as a potential reservoir for Ebola virus after initial clinical recovery in a population of patients who survived Ebola virus disease.
This case series describes alemtuzumab-induced neutropenia in 2 patients with multiple sclerosis.